Search

everythinglearnresearchcommunity

for

Search:↓

Dutasteride 0.5 mg works better than finasteride and placebo for increasing hair in men with hair loss.

Young women in West Bengal, India, with PCOS often have estrogen resistance, leptin receptor issues, folate deficiency, T2DM, and acanthosis, commonly linked to obesity.

Patients with mood disorders using 5α-reductase inhibitors may have a higher risk of suicidal thoughts.

Finasteride, a hair loss medication, was found to be safe and effective in improving hair quality and stopping hair loss in men with early-onset baldness.

Advancements in male reproductive medicine are ongoing, but more research and improved treatments are needed in several areas.

Bicalutamide effectively treats prostate cancer but needs careful monitoring for side effects.

Long-term testosterone therapy can cause hormone suppression, affect prostate and heart health, and alter physical characteristics, but does not increase prostate cancer risk and needs more research for full risk assessment.

Cyproterone acetate may cause liver cancer at high doses, but is considered safe at recommended doses for approved uses.

After prostate removal surgery, higher initial prostate size was linked to higher urethral PSA levels and more severe male pattern baldness.

Benign Prostatic Hyperplasia may be caused by changes in how the body processes male hormones.

New compounds can block testosterone effects in rats and might help treat conditions like prostate cancer and acne.

Prostate cancer can progress even with low testosterone due to internal hormone production in the tumor.

Early hair loss may indicate future prostate issues.

Finasteride treats hair loss but may cause side effects like low libido and dizziness.

Finasteride reduces prostate size and PSA levels in young men with hair loss.

Shorter PSADT after prostate surgery is linked to higher risk of death.

Hair loss is linked to higher prostate-specific antigen levels and urinary symptoms, likely due to age.

Testosterone therapy increases bone density in older men with low testosterone levels.

Finasteride affects male rat genitalia development, causing abnormalities during specific pregnancy days.

Smaller substituents at C-17 enhance the inhibitory activity of progesterone derivatives on 5alpha-reductase.

Androgen deprivation therapy doesn't lower the risk of death from COVID-19 in prostate cancer patients.

Dihydrotestosterone gel improved well-being and sexual function in older men without negatively affecting prostate health.

Scientists made the first metal-based compounds from a nonsteroidal antiandrogen drug, which showed potential in fighting both hormone-dependent and independent prostate cancer cells.

Low androgen levels might delay prostate cancer but could lead to more aggressive, therapy-resistant cancers.

Too much AKR1C3 enzyme causes resistance to finasteride by increasing testosterone.

Finasteride treats enlarged prostate and baldness, but may cause limited urinary improvement and sex-related side effects.

Certain inhibitors can potentially treat prostate cancer and other hormone-dependent conditions by controlling sex hormone levels in cells.

The new compounds moderately block a specific enzyme and strongly counteract a male hormone, suggesting potential for treating certain male-related health conditions.

Finasteride reduces prostate cancer risk by 30% without affecting Gleason scores.

A new compound that could treat various androgen-related conditions was created and analyzed.